Recent advances in genome editing technology are accompanied by increasing public expectations on its potential clinical application, but there are still scientific, ethical, and social considerations that require resolution. In Japan, discussions pertaining to the clinical use of genome editing in human embryos are underway. However, understanding of the public’s sentiment and attitude towards this technology is limited which is important to help guide the debate for prioritizing policies and regulatory necessities. Thus, we conducted a cross-sectional study and administered an online questionnaire across three stakeholder groups: the general public, patients and their families, and health care providers. We received responses from a total of 3,511 individuals, and the attitudes were summarized and compared among the stakeholders. Based on the distribution of responses, health care providers tended to be cautious and reluctant about the clinical use of genome editing, while patients and families appeared supportive and positive. The majority of the participants were against the use of genome editing for enhancement purposes. Participants expressed the view that clinical use may be acceptable when genome editing is the fundamental treatment, the risks are negligible, and the safety of the technology is demonstrated in human embryos. Our findings suggest differences in attitudes toward the clinical use of genome editing across stakeholder groups. Taking into account the diversity of the public’s awareness and incorporating the opinion of the population is important. Further information dissemination and educational efforts are needed to support the formation of the public’s opinion.
Your institute does not have access to this article
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Doudna JA. The promise and challenge of therapeutic genome editing. Nature 2020;578:229–36.
Shim G, Kim D, Park GT, Jin H, Suh SK, Oh YK. Therapeutic gene editing: delivery and regulatory perspectives. Acta Pharm Sin. 2017;38:738–53.
Kelly EO, Yvonne B, Vence LB, Lily HA, Heidi CH, Rosario I, et al. The clinical application of gene editing: ethical and social issues. Pers Med. 2019;16:337–50.
Coller BS. Ethics of human genome editing. Annu Rev Med. 2019;70:289–305.
Armsby AJ, Bombard Y, Garrison NA, Halpern-Felsher BL, Ormond KE. Attitudes of members of genetics professional societies toward human gene editing. CRISPR J 2019;2:331–9.
Science Council of Japan. Statemen: Ethical Justification for the Use of Genome Editing Technology for Human Reproduction. 2020. https://www.scj.go.jp/ja/info/kohyo/pdf/kohyo-24-t292-5.pdf
Kleiderman E, Stedman INK. Human germline genome editing is illegal in Canada, but could it be desirable for some members of the rare disease community? J Commun Genet. 2020;11:129–38.
Health Sciences Council, Ministry of Education, Culture, Sports, Science and Technology and Ministry of Health, Labour and Welfare. Expert Committee on the Clinical Use of Human Fertilized Embryos Using Genome Editing Technology, etc. Technical Committee on the Clinical Use of Human Fertilized Embryos Summary of Discussions. 2020. https://www.mhlw.go.jp/content/000582921.pdf
Treleaven T, Tuch BE. Australian public attitudes on gene editing of the human embryo. J Law Med. 2018;26:204–7.
Ministry of Health, Labour and Welfare. Guidelines for Gene Therapy Clinical Research, 2019. https://www.mhlw.go.jp/content/000561788.pdf
Ministry of Education, Culture, Sports, Science and Technology and Ministry of Health, Labour and Welfare. Creating Human Embryos Ethical Guidelines for Assisted Reproductive Clinical Research, 2010. https://www.mhlw.go.jp/general/seido/kousei/i-kenkyu/dl/9_01.pdf
Ministry of Education, Culture, Sports, Science and Technology and Ministry of Health, Labour and Welfare. Ethical Guidelines for Research Using Genetic Information Modification Technology on Human Embryos, 2019. https://www.mhlw.go.jp/content/000822403.pdf
Scheufele DA, Xenos MA, Howell EL, Rose KM, Brossard D, Hardy BW. U.S. attitudes on human genome editing. Science 2017;357:553–4.
Governance WHOHE. Human Genome Editing: Recommendations. World Health Organization. 2021.
Delhove J, Osenk I, Prichard I, Donnelley M. Public acceptability of gene therapy and gene editing for human use: a systematic review. Hum Gene Ther. 2020;31:20–46.
Jedwab A, Vears DF, Tse C, Gyngell C. Genetics experience impacts attitudes towards germline gene editing: a survey of over 1500 members of the public. J Hum Genet. 2020;65:1055–65.
Uchiyama M, Nagai A, Muto K. Survey on the perception of germline genome editing among the general public in Japan. J Hum Genet. 2018;63:745–8.
Taguchi I, Yamada T, Akaishi R, Imoto I, Kurosawa K, Nakatani K, et al. Attitudes of clinical geneticists and certified genetic counselors to genome editing and its clinical applications: A nation-wide questionnaire survey in Japan. J Hum Genet. 2019;64:945–54.
Watanabe D, Saito Y, Tsuda M, Ohsawa R. Increased awareness and decreased acceptance of genome-editing technology: The impact of the Chinese twin babies. PLoS One. 2020;15:e0238128.
Japan Patients Association. https://nanbyo.jp/jpatowa/kamei/ Accessed 05 Feb 2022.
Approved Specified Nonprofit Corporation The Support Network for NANBYO Children of Japan. https://www.nanbyonet.or.jp/outline/ Accessed 05 Feb 2022.
McCaughry T, David MB, Paul GS, George ECG, Li F, Eva F, et al. A need for better understanding is the major determinant for public perceptions of human gene editing. Hum Gene Ther. 2019;30:36–43.
Hoffman-Andrews L, Mazzoni R, Pacione M, Garland-Thomson R, Ormond KE. Attitudes of people with inherited retinal conditions toward gene editing technology. Mol Genet Genom Med. 2019;7:e00803.
Gaskell G, Bard I, Allansdottir A, da Cunha RV, Eduard P, Hampel J, et al. Public views on gene editing and its uses. Nat Biotechnol. 2017;35:1021–3.
McCaughey T, Sanfilippo PG, Gooden GE, Budden DM, Fan L, Fenwick E, et al. A global social media survey of attitudes to human genome editing. Cell Stem Cell. 2016;18:569–72.
Fitz NS, Nadler R, Manogaran P, Chong EWJ, Reiner PB. Public attitudes toward cognitive enhancement. Neuroethics. 2013;7:173–88.
Vermeulen E, Henneman L, van El CG, Cornel MC. Public attitudes towards preventive genomics and personal interest in genetic testing to prevent disease: a survey study. Eur J Public Health. 2014;24:768–75.
This work was supported by a grant from the Health Labor Sciences Research Grant (20CA2005). We thank the Japan Patients Association, Approved Specified Nonprofit Corporation the Support Network for NANBYO Children of Japan, the Japan Society of Obstetrics and Gynecology, the Japan Pediatric Society, the Japan Society of Perinatal and Neonatal Medicine and the Japan Society of Human Genetics. We are grateful to our study support staff and, most importantly, survey participants for their contribution to this study.
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kobayashi, S., Miyoshi, T., Kobayashi, T. et al. Public attitudes in the clinical application of genome editing on human embryos in Japan: a cross-sectional survey across multiple stakeholders. J Hum Genet 67, 541–546 (2022). https://doi.org/10.1038/s10038-022-01042-z